iPLEDGE Program Explained: What Each Patient Group Does
Quick answer: The iPLEDGE program is an FDA Risk Evaluation and Mitigation Strategy, or REMS. The FDA calls it a shared system that includes all FDA-approved isotretinoin products. It exists because the Accutane label warns of an extremely high risk of life-threatening birth defects if pregnancy occurs during treatment. MedlinePlus says all patients can get isotretinoin only if they are registered with iPLEDGE, and that you will need to see your doctor every month during treatment. Patients who can get pregnant also have pregnancy tests and answer iPLEDGE questions monthly during therapy. This page is current as of October 14, 2026.
Below, you will find what the program is, what each patient group does, and what a typical month looks like. The rules come from the FDA, the Accutane label on DailyMed, MedlinePlus and the American Academy of Dermatology. Some rules are planned to change on November 15, 2026, and we date each of those so you can tell what applies today.
What is the iPLEDGE program, and why does it exist?
REMS stands for Risk Evaluation and Mitigation Strategy. The FDA’s iPLEDGE page says it is a “shared system” REMS, meaning that it includes all FDA-approved isotretinoin products. Brand and generic isotretinoin therefore follow one program.
The reason for all of it is pregnancy risk. The Accutane label says there is an extremely high risk that life-threatening birth defects will result if pregnancy occurs while taking Accutane. That risk applies in any amount, even for short periods of time. MedlinePlus adds a high risk of pregnancy loss, early birth, or a baby who dies shortly after birth.
The program links the patient, the prescriber and the pharmacy. Your prescriber enrolls you, your pharmacy must be registered, and the pharmacist gets an authorization from the system before filling each prescription. The label says Accutane must be dispensed after authorization from the iPLEDGE REMS, in no more than a 30-day supply, with a new prescription for refills.
For a deeper look at the rules and the FDA documents behind them, see our post on iPLEDGE REMS. For a checklist, see our iPLEDGE requirements checklist.
Who has to do what in the iPLEDGE program?
Two risk categories exist: patients who can get pregnant and patients who cannot get pregnant. The FDA page says that starting December 13, 2021, providers must assign and confirm each currently enrolled patient’s risk category upon first login. That is the first login on or after that date. Ask your prescriber for your category.
What rules apply to every patient?
MedlinePlus says all patients, including women who cannot become pregnant and men, can get isotretinoin only if they are registered with iPLEDGE. They also need a prescription from a registered doctor and a registered pharmacy. It also says not to buy isotretinoin over the internet. The label says Accutane must not be obtained through the internet outside of the iPLEDGE REMS, and only at US licensed pharmacies.
Per the label, every patient must sign a patient enrollment form. No patient may donate blood while on isotretinoin or for one month after treatment ends. No patient may share isotretinoin, even with someone who has similar symptoms.
What do patients who can get pregnant do?
This group has the most steps. The label lists these requirements for patients who can become pregnant:
- Two negative pregnancy tests before the first prescription. The second is a confirmation test in a CLIA-certified laboratory, and the interval between the two should be at least 19 days.
- Two separate forms of effective birth control at the same time, starting one month before treatment and ending one month after it stops. The label lists exceptions, such as continuous abstinence.
- Contact with the iPLEDGE system before starting, monthly during therapy and one month after the last dose, to answer program questions and enter the two chosen forms of contraception.
- A second enrollment form, because the Medication Guide says patients who can get pregnant must sign another one.
What do patients who cannot get pregnant do?
MedlinePlus says a man, or a woman who cannot become pregnant, must have the prescription filled and picked up within 30 days of the doctor visit. Your prescriber assigns your category, and our iPledge FAQ says a tubal ligation does not qualify for the cannot-get-pregnant category. The Medication Guide says that before prescribing, your doctor will explain the iPLEDGE REMS to you and have you sign the Patient Enrollment Form for Patients who cannot get Pregnant.
The label‘s monthly table marks the patient questions and contraception entries only for patients who can become pregnant. So the monthly questions on the program requirements are not yours to answer in this group, and the label lists no monthly attestation for you either.
What do prescribers and pharmacists do?
The label’s monthly table has the prescriber confirm patient counseling. For patients who can become pregnant, the prescriber also enters the two contraception forms and the pregnancy test results. The pharmacist contacts the system to get an authorization for every prescription. Prescriptions are for no more than a 30-day supply, and the label allows no automatic refills.
What does a month on isotretinoin look like?
The monthly cycle repeats until treatment ends. Both groups see the prescriber, because the AAD says a doctor can only prescribe isotretinoin for 30 days at a time. To get a refill, you check in with your dermatologist, either in person or virtually through telemedicine. The AAD adds that these check-ins let you describe how you feel and mention any change, even one that seems unrelated.
A month for patients who can get pregnant
The MedlinePlus isotretinoin page says you contact the iPLEDGE system by phone or the internet every month. You confirm your two forms of birth control and answer two questions about the program. You can only continue to get isotretinoin if you have done that, visited your doctor, and had a negative pregnancy test within the past 7 days.
The label then gives the pickup rule. You must obtain the prescription within 7 days of the date the pregnancy test sample was collected. The clock starts at the sample date, not the result date, so waiting for a result uses up part of the window.
Our guide to how to get Accutane prescribed explains what happens before the first prescription.
A month for patients who cannot get pregnant
You still see your prescriber, and your prescriber and pharmacist handle the iPLEDGE entries. The label says you must obtain the prescription within 30 days of the office visit. Today, the monthly table lists no pregnancy test or patient question for you.
The label’s table shows the prescriber confirming patient counseling each month for both groups today. That is a prescriber step, not something you enter yourself.
What if you miss the pickup window?
The label says that after the “Do Not Dispense To After” date, the authorization must be reversed and the product returned to inventory. That means the pharmacy cannot fill it. What comes next differs by group. If a patient who can get pregnant does not obtain isotretinoin within the first 7-day prescription window, the FDA plans to remove the waiting period it calls the 19-day lockout. Until that change, the waiting period still applies. The label’s separate “at least 19 days” is only the interval between the two pre-treatment tests. Our post on iPLEDGE REMS links the details.
How do you register and log in to iPLEDGE?
Searches for the iPLEDGE login are common, so here is what the sources say. The iPLEDGE patient troubleshooting tips say that after your prescriber enrolls you, you receive an email with an invitation link to set your username and password. If you forget either, use the “Forgot Username?” or “Forgot password?” link on the iPLEDGE website.
If no reset email arrives, the same tips say to check that the address is active and spelled correctly, and to look in your spam or junk folder. The tips say to contact the Contact Center if it still does not arrive. The Medication Guide gives the iPLEDGE REMS phone number as 1-866-495-0654 and the website as ipledgeprogram.com. MedlinePlus says your doctor will give you an identification number and card when you start treatment, and you will need this number to fill your prescriptions.
Can you use a home pregnancy test with iPLEDGE?
For patients who can get pregnant, the FDA’s October 2023 enforcement discretion already covers home tests. That allowance does not start on November 15, 2026. Until the modifications are fully implemented, the FDA says it will continue to exercise enforcement discretion on pregnancy testing, as described in its October 2023 update. Under that update, the FDA does not intend to object if prescribers rely on patient-performed home tests, reported with dates and results, during and after isotretinoin treatment.
The same update says all pre-treatment pregnancy tests must be performed in a medical setting, such as an office or laboratory. Our iPledge FAQ says that for a telehealth patient, a medical setting means a lab. Prescribers still interpret and document every result in the iPLEDGE system.
The label still says a pregnancy test must be repeated every month in a CLIA-certified laboratory before a patient who can become pregnant receives each prescription. Under the October 2023 enforcement discretion, the FDA does not intend to object if a prescriber relies on a patient-performed home test during and after treatment. Whether yours does is your prescriber’s decision.
What changes are planned for November 15, 2026?
The changes in this section are not in effect as of October 14, 2026. The FDA approved modifications to the iPLEDGE REMS on February 9, 2026. The agency first scheduled them for August 8, 2026, then moved the planned date to November 15, 2026. Because the date has already slipped once, check the FDA page for the current status.
Per the FDA page, once the changes take effect, there will no longer be a 30-day prescription window for patients who cannot get pregnant. The label still says isotretinoin is dispensed in no more than a 30-day supply, and the FDA’s list of planned changes does not mention that cap. The 19-day lockout will be removed for a patient who can get pregnant who misses the first 7-day window, and a repeat pregnancy test may be done right away. If that patient has not had a first dose, the repeat test must be done in a medical setting. Patients who cannot get pregnant must be counseled at enrollment, and prescribers should reinforce counseling throughout treatment. Monthly documentation of that counseling in the REMS will no longer be required. Until then, the rules in the sections above still apply.
The FDA says all pre-treatment pregnancy tests must be performed in a medical setting, both now and after the planned changes. Home tests during and after treatment are the October 2023 allowance, not a November 15 change.
Common questions about the iPLEDGE program
What is iPLEDGE for Accutane? It is the FDA-required REMS that includes all FDA-approved isotretinoin products, including generics. Your prescriber, your pharmacy and you each have a role.
Do I have to log in to iPLEDGE every month? If you can get pregnant, the label has you contact the system monthly during therapy to answer program questions and enter your two forms of contraception. If you cannot get pregnant, the label’s monthly table lists no patient step, though you still see your prescriber each month during treatment.
How long do I have to pick up my prescription? As of October 14, 2026, it is 7 days from the pregnancy test sample date if you can get pregnant, per the label. If you cannot get pregnant, it is 30 days from the office visit, and the FDA plans to remove that window on November 15, 2026.
Can I take a home pregnancy test instead of going to a lab? If you can get pregnant, the label still says each monthly pregnancy test must be done in a CLIA-certified laboratory. Under the October 2023 update, the FDA does not intend to object if your prescriber relies on a home test you report during and after treatment. Every pre-treatment test must be done in a medical setting.
Do the November 15, 2026 changes apply now? No, they are not in effect as of October 14, 2026. The FDA approved them on February 9, 2026 and planned implementation for November 15, 2026, so check the FDA page for the current status.
What should you do before your next visit?
Ask your prescriber which group you are in and when your next window opens. Write down your identification number, and keep the iPLEDGE phone number from your Medication Guide. If your course crosses November 15, 2026, ask what changes for your next fill.
If you want a board-certified dermatologist to look at your acne, take the quiz, which takes about two minutes. Accutane Care at The Goal Is Clear includes an iPledge concierge that tracks every window, test and refill. Read our iPledge FAQ, our Accutane FAQ and our Accutane cost FAQ. The cost on our pricing page is as low as $0 for the prescription with insurance. Our guides to side effects, generic versus brand and Accutane versus tretinoin cover the rest of the course.
This article is general information, not medical advice. A prescription is never guaranteed, and treatment decisions stay with the board-certified dermatologist who reviews your case. Accutane® is a registered trademark of its respective owner, and isotretinoin is the generic name. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician. Independent board-certified dermatologists prescribe the medication.
Sources
General information from published sources, not medical advice. Your dermatologist makes every treatment decision after reviewing your case. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician.
← Blog Home